Tim Wilens, MD, discussed mechanism of action and efficacy of new medications at APSARD Conference.

Clinicians explore the complex relationship between ADHD medication and pregnancy, emphasizing individualized risk assessments for optimal maternal and child health.

Adults who receive an ADHD diagnosis later in life may represent a somewhat less severe clinical subtype than those diagnosed in youth, but still experience impairment that warrants clinical attention, according to new data presented at American Professional Society of ADHD and Related Disorders (APSARD) 2026 Annual Conference.1,2

Key point: Compared with standard aerobic exercise, cognitively engaging exercise programs improved sustained attention of children and adolescents with ADHD, with multiple longer sessions having a more significant effect.

A large multicentre clinical trial led by King’s College London with 150 children and adolescents has shown that a device cleared by the US FDA to treat ADHD is not effective in reducing symptoms.

People who have ADHD traits at age 10 are more likely than those without such traits to have physical health problems and to report physical health-related disability at age 46, according to a study led by University College London (UCL) and University of Liverpool researchers.

The review looked at more than three dozen studies and found no evidence that acetaminophen increased the risk of neurodevelopmental disorders in children.

Key Takeaways: Dr. Maggie Sibley highlighted common barriers in ADHD treatment for adolescents and their parents, emphasizing the need for effective engagement strategies in behavior therapy. Data presented showed significant differences in educational, vocational, and financial outcomes for individuals diagnosed with ADHD in childhood. Understanding and addressing treatment barriers is crucial for improving long-term outcomes…

Key Takeaways: Misconceptions about ADHD’s genetic basis and environmental influences were highlighted, emphasizing the need for accurate understanding in clinical practice. Presenters discussed challenges in medication selection, stressing the importance of personalized approaches to ADHD treatment. The limitations of neuropsychological testing in ADHD diagnosis were addressed, underscoring the need for comprehensive assessment strategies. Debunking myths…

Attention-Deficit Hyperactivity Disorder, or ADHD, affects tens of millions of people in the U.S. About one in nine children and one in 16 adults have ADHD. That’s according to an analysis from the nonprofit Children and Adults with Attention-Deficit/Hyperactivity Disorder, or CHADD. As researchers learn more about the brain and its complexities, they’re also gaining…

The NHS is overspending by £164m a year on attention deficit hyperactivity disorder (ADHD) services, with an increasing amount going to unregulated private assessments, a Guardian investigation has found.

[Excerpt] In one study, Traci M. Kennedy, of the University of Pittsburgh, and her colleagues, studied a mobile-health intervention specifically tailored toward young adults with attention-deficit/hyperactivity disorder (ADHD) at high risk for heavy drinking. Participants received frequent check-ins via their smartphones to help identify patterns in ADHD symptoms and their drinking. Based on their responses,…